New Clinical Guidelines for the Management of Hypertension
12.00
Learning Objectives
Upon completion of this course the learner should be able to:
Upon completion of this course the learner should be able to:
- Characterize the different stages of high blood pressure including elevated blood pressure, Stage 1 hypertension, Stage 2 hypertension, and hypertensive crisis.
- Distinguish between primary (also known as essential) and secondary hypertension.
- Describe two myths associated with the symptoms of hypertension.
- Name three factors implicated in the development of hypertension.
- Identify three components of the DASH diet.
- Name one antihypertensive agent identified by JNC 8 for initial treatment of black hypertensive patients.
- List three class side effects associated with the use of beta blockers.
- Identify one advantage of combination drug product use to treat hypertension.
- Describe one potentially neurologic abnormality that is associated with a hypertensive emergency.
View Requirements
Want Unlimited CE? Become a Member
New Clinical Guidelines for the Management of Hypertension
12.00
Learning Objectives
Upon completion of this course the learner should be able to:
Upon completion of this course the learner should be able to:
- Characterize the different stages of high blood pressure including elevated blood pressure, Stage 1 hypertension, Stage 2 hypertension, and hypertensive crisis.
- Distinguish between primary (also known as essential) and secondary hypertension.
- Describe two myths associated with the symptoms of hypertension.
- Name three factors implicated in the development of hypertension.
- Identify three components of the DASH diet.
- Name one antihypertensive agent identified by JNC 8 for initial treatment of black hypertensive patients.
- List three class side effects associated with the use of beta blockers.
- Identify one advantage of combination drug product use to treat hypertension.
- Describe one potentially neurologic abnormality that is associated with a hypertensive emergency.